Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peripheral nerve myelin sheath is a specialized, lipid-rich membrane produced by Schwann cells that spirally wraps around axons in the peripheral nervous system[2][7][9][5]. This sheath consists of up to hundreds of concentric layers, with each segment termed an internode and separated by nodes of Ranvier, where rapid signal “jumping” (saltatory conduction) takes place[7]. The membrane is composed mostly of lipids (70–80%) and proteins (20–30%), most notably myelin protein zero (P0), peripheral myelin protein 22 (PMP22), and myelin basic protein (MBP)[1][6][8]. The sheath insulates axons, enables rapid signal transmission, and helps maintain axon health and regeneration after injury[7][9]. Damage or genetic abnormalities in sheath components cause various peripheral neuropathies and inherited myelin disorders[3][6]. While the sheath itself is not a primary drug target, its failure is a crucial element in several neurological diseases.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral nerve myelin sheath.